InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: None

Friday, 08/12/2016 11:13:23 AM

Friday, August 12, 2016 11:13:23 AM

Post# of 5005
Journal of Ocular Pharmacology and Therapeutics
Novel Hydrophobically Modified Asymmetric RNAi Compounds (sd-rxRNA) Demonstrate Robust Efficacy in the Eye
http://online.liebertpub.com/doi/abs/10.1089/jop.2013.0148

Reason why I think the retinal scarring trial will drive RXII's value faster than how dermal scarring trials have been able to do.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News